ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,631.22
0.00%
US Tech 100
19,888.80
0.22%
Dow Jones
40,211.72
0.00%
Brent Oil
83.055
-1.52%
Bitcoin
63,952.63
-1.39%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tempest Therpeutics Inc (TPST)

  7. Tempest Therpeutics Inc (TPST) News

TPST

Tempest Therpeutics (TPST)

Tempest Therpeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TPST
DateTimeSourceHeadlineSymbolCompany
11/20/20238:00AMGlobeNewswire Inc.Tempest to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:TPSTTempest Therpeutics Inc
11/17/20234:46PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
11/17/20234:45PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
11/17/20234:44PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
11/17/20234:44PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
11/17/20234:43PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
11/17/20234:39PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TPSTTempest Therpeutics Inc
11/09/20235:28PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
11/08/20235:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TPSTTempest Therpeutics Inc
11/08/20235:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
11/08/20235:17PMGlobeNewswire Inc.Tempest Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
11/02/20234:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TPSTTempest Therpeutics Inc
10/30/20236:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
10/13/20234:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
10/13/20234:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
10/13/20234:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
10/13/20234:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
10/12/20236:06AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TPSTTempest Therpeutics Inc
10/11/20238:29AMEdgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:TPSTTempest Therpeutics Inc
10/11/20238:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
10/11/20238:01AMGlobeNewswire Inc.Tempest Adopts Limited Duration Stockholder Rights PlanNASDAQ:TPSTTempest Therpeutics Inc
10/11/20238:00AMGlobeNewswire Inc.Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC StudyNASDAQ:TPSTTempest Therpeutics Inc
10/10/20234:05PMGlobeNewswire Inc.Tempest to Report New and Updated Data from Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular CarcinomaNASDAQ:TPSTTempest Therpeutics Inc
09/19/20238:00AMGlobeNewswire Inc.Tempest Announces Expanded Role for Sam Whiting, M.D., Ph.D., as Chief Medical Officer and Head of Research and DevelopmentNASDAQ:TPSTTempest Therpeutics Inc
09/08/20234:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
09/07/20234:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
09/05/20238:00AMGlobeNewswire Inc.Tempest to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:TPSTTempest Therpeutics Inc
08/10/20234:39PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TPSTTempest Therpeutics Inc
08/10/20234:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
08/10/20234:13PMGlobeNewswire Inc.Tempest Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPST

Your Recent History

BIT
UC1H0C
Unicredit Bank
LSE
0LY9
Fabryka Obrabiarek Rafamet
LSE
INTU
Intu Properties
NASDAQ
FBIZ
First Business Financial...
TSXV
HET
LSE
0DGZ
Adolfo Dominguez
BIT
UC8FQX
Unicredit Bank
NYSE
DCP.PRC
DCP Midstream, LP
LSE
MI88
Citi Fun 25
NASDAQ
LOCO
El Pollo Loco
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved